LAST month, the U. S. Food and Drug Administration (FDA) has approved the first generic version of the statins Crestor and Rosuvastatin in a single-dose, once-a-day regimen, as an adjunct to other therapies in the management of type 2 diabetes.
Crestor is currently the first approved treatment in the treatment of type 2 diabetes in the U. It has been shown to significantly improve glycemic control in patients with type 2 diabetes and has been shown to modestly reduce the risk of cardiovascular events in patients with type 1. This approval marks the first FDA-approved indication for Crestor in this population.
The new, once-daily, oral treatment for type 2 diabetes, along with the Crestor, is a combined therapy to manage patients with high blood pressure, heart failure, and diabetic ketoacidosis. It is administered every 3 weeks in patients with uncontrolled hypertension.
The new Crestor dosage has been developed as a single-dose, once-a-day medication, which is FDA-approved for the treatment of high blood pressure in adults.
The new Crestor dose, which is currently available in the U. as 20 mg or 40 mg capsules, is also approved by the FDA for the treatment of patients with type 2 diabetes.
as 20 mg or 40 mg tablets, is also approved by the FDA for the treatment of patients with type 1 diabetes.
“Our new approval represents a significant milestone in the treatment of patients with type 2 diabetes,” said lead investigator Dr. Michael J. Henning, M. D., Ph. D., and co-lead investigator of the FDA-approved treatment, Crestor.
The new Crestor dosage is currently available in the U. as 20 mg or 40 mg capsules. The 40 mg dose will be manufactured by AstraZeneca Pharmaceuticals and will be marketed as a generic, or as an oral version of Crestor.
Crestor, as part of a new treatment for type 2 diabetes, has been shown to significantly improve glycemic control in patients with uncontrolled hypertension, including those with diabetic ketoacidosis.
“The first oral treatment for patients with type 2 diabetes is a first-line treatment for patients with high blood pressure and heart failure, and we are proud to bring this approval to the forefront,” said Henning, who will continue to serve as lead investigator for the FDA-approved indication of the new Crestor.
This approval marks the first FDA-approved indication for the treatment of type 2 diabetes in this population.
Crestor is the first approved treatment for patients with type 2 diabetes in the U. The new drug for patients with diabetes, Crestor, has been shown to significantly improve glycemic control in patients with uncontrolled hypertension, including those with diabetic ketoacidosis.The Crestor dosage will be available in the U.
The Crestor 40 mg dosage has been approved by the FDA as the first oral treatment for patients with type 2 diabetes.
“These are some of the first FDA-approved indications for treating patients with type 2 diabetes, and we look forward to providing these treatments to patients with diabetes in the U. S.,” said Henning, who will continue to serve as lead investigator for the FDA-approved indication of the new Crestor.
Crestor, as part of a new treatment for patients with type 2 diabetes, has been shown to significantly improve glycemic control in patients with uncontrolled hypertension, including those with diabetic ketoacidosis.
Crestor, containing rosuvastatin, is a widely prescribed statin medication for managing cholesterol levels. It lowers LDL (bad cholesterol) and triglycerides while raising HDL (good cholesterol), reducing the risk of cardiovascular complications such as heart attacks and strokes. It is a trusted choice for individuals at risk of heart disease or those with high cholesterol.
Benefits of Crestor:
Dosage:
Warnings and Precautions:
Usage Instructions:
Storage Information:
Common Side Effects:
More information about Crestor:
References:The information provided on this website is not intended for everyone. This is a medical advice for information only. It is not used for diagnosing, treating, or preventing any disease. It is only helpful for men and women. Always discuss the risks and benefits of this medication with your doctor. Before taking this medication, tell your doctor if you are taking or have recently taken any medications. This medication should not be taken within 5 days of receiving a prescription from your doctor.
AstraZeneca has warned that the cost of the cholesterol drug Crestor may rise from being a key component of its treatment plan for patients who suffer from high cholesterol.
The company said it is consulting with regulators to determine the best course of action to ensure that patients with high cholesterol are treated to reduce the risk of heart attack and stroke.
The warning was based on results from two large clinical trials that showed the drug may lead to the development of more than 10,000 heart attacks and strokes in patients with high cholesterol.
The results of the clinical trial on cholesterol lowering treatment showed a higher rate of heart attacks and strokes in those who had low-density lipoprotein levels, and at high risk for heart attack and stroke.
The company said it has also urged patients to stop taking the cholesterol-lowering drug and to seek advice from their doctors if they develop chest pain, fever or fatigue, according to the announcement.
Health officials said the company has not yet made any decisions about the potential risks, although the company has been in discussions with regulators over the matter.
The company said the findings in its clinical trial showed that patients who had a small but significant increase in cholesterol levels during treatment were at an increased risk of cardiovascular events, such as heart attack and stroke. The company said it is consulting with regulators and will decide on the best course of action.
The study, which involved 6,600 patients with high cholesterol, found that patients on Crestor who had a small but significant increase in cholesterol levels had a 40 per cent increased risk of heart attack, stroke or coronary heart disease. The researchers did not report the full risk, which would require a subsequent trial.
The company said it is working with regulators to monitor the results in future trials. It has said it has been informed that the trial was done to ensure that patients continue to have a high risk of heart attacks, strokes or coronary heart disease, and is not recommended to stop taking the drug.
The company is not giving specific instructions to patients on how to take the cholesterol-lowering drug Crestor.
The drug is not currently approved by the U. S. Food and Drug Administration for the treatment of high cholesterol.
The company said Crestor is currently being sold by AstraZeneca under the brand name Zocor, and its patent expires in the U. in 2019.
Crestor, or rosuvastatin, is a prescription drug used to treat high cholesterol, high blood pressure and type 2 diabetes.
Originally Published: January 1, 2012 at 5:08 PM MDT
Read MoreThe Crestor study was sponsored by the Merck & Co.'s Lipitor, which had a global sales of $1.3 billion in 2008. The company had planned to conduct the trial later this year.
Photo: Getty ImagesThe company said it was reviewing the results of the trial and is consulting with regulators.
“The results of the study are reassuring,” AstraZeneca said in a statement.
“We believe that the results in this study provide a baseline for further monitoring of Crestor use in patients who have cardiovascular disease, and that this review will enable us to make an informed decision about the best course of action for patients with high cholesterol who are being treated with Crestor,” the company said.
In its statement, Crestor’s U. sales were up 30 per cent from the previous quarter.
The company said the results showed that Crestor is likely to be a key component of the treatment plan for patients with high cholesterol.
“These results should be considered in light of clinical data that has shown the efficacy of Crestor in lowering triglyceride levels in patients with low triglyceride levels,” it said.
“These results should also be considered as the primary goal of the treatment plan for patients with high cholesterol.”
The company did not respond to a request for comment.
The company has not commented on a response from the FDA.
The company did not return a phone call from a reporter who asked about the company's safety.
The company said the results in its clinical trial showed that patients who had a small but significant increase in cholesterol levels during treatment were at an increased risk of heart attack, stroke or coronary heart disease. The study did not report the full risk.
AstraZeneca's Crestor is a prescription medication used to lower cholesterol and reduce the risk of heart attack and stroke, in people who are at risk for cardiovascular disease. It works by blocking the enzyme statin that causes your body to convert more cholesterol into fatty substances. The medication is available in tablet form, typically as a 20mg tablet. If you are prescribed Crestor, you will need to take a high-fat meal before your statin prescription, as it may reduce the effectiveness of the medication. This means taking Crestor with a meal to reduce the chance of stomach upset. It's important to note that the Crestor can only be prescribed by a healthcare provider, and it should only be used under the guidance of a physician. The medication should not be used for more than three months, so if you have been prescribed Crestor for more than three months, it may be necessary to take it longer.
Crestor is a prescription medication used to reduce the risk of heart attack and stroke, in people who are at risk for cardiovascular disease.This product requires a Prescription Required.
Compare prices from different suppliers, and find the best price for your medication.
Generic Crestor is available at much lower prices than brand Crestor. The generic version of Crestor, rosuvastatin, is also available at much lower prices than generic Crestor.
Generic Crestor 10mg, manufactured by AstraZeneca, is available at much lower prices than brand Crestor.
Compare prices from different manufacturers, and find the best price for your medication.
Generic Crestor 20mg, manufactured by AstraZeneca, is available at much lower prices than brand Crestor.
Stade de France Pharmacy